Chlamydia & Gonorrhea Most Popular

The Chlamydia & Gonorrhea test contains 1 test with 2 biomarkers.

Chlamydia/Neisseria gonorrhoeae RNA, TMA

Patient Preparation 

Urine specimen: The patient should not have urinated for at least one hour prior to specimen collection. Female patients should not cleanse the labial area prior to providing the specimen.

Urine: Patient should not have urinated within one hour prior to collection. Female patients should not cleanse the labial area prior to providing the specimen. Direct patient to provide a first-catch urine (a maximum of 20-30 mL of the initial urine stream) into a urine collection cup free of any preservatives. 2 mL of urine specimen must be transferred into the APTIMA® specimen transport within 24 hours of collection and before being assayed. Use tube provided in the urine specimen collection kit for urine specimens. The fluid (urine plus transport media) level in the urine tube must fall within the clear pane on the tube label.

 

Clinical Significance

C. trachomatis infections are the leading cause of sexually transmitted diseases in the United States. C. trachomatis is known to cause cervicitis, pelvic inflammatory disease (PID), epididymitis and proctitis. It is also the most frequent cause of non-gonococcal urethritis in men. Among women, the consequences of Chlamydialinfections are severe if left untreated. Approximately half of Chlamydial infections are asymptomatic.
Neisseria gonorrhoeae (gonococci) is the causative agent of gonorrhea. In men, this disease generally results in anterior urethritis accompanied by purulent exudate. In women, the disease is most often found in the cervix, but the vagina and uterus may also be infected.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: ChlamydiaNeisseria gonorrhoeae RNA TMA, CT/GC APTIMA®, CT/GC TMA, CT/NG APTIMA®, CT/NG TMA, Hologic

Chlamydia Trachomatis

This test is looking for evidence of infection by the bacterium Chlamydia trachomatis. Chlamydia is the most common bacterial sexually transmitted disease (STD) in the United States. About 75% of infected women and 50% of infected men have no symptoms; some may experience only mild symptoms. For women, symptoms, if they occur, include bleeding between menstrual periods and after sexual intercourse, abdominal pain, painful intercourse, and an abnormal vaginal discharge. For men, symptoms include pus or milky discharge from the penis and inflammation of the prostate (prostatitis) or of the rectal area (proctitis). Both sexes can experience painful or frequent urination.

Neisseria Gonorrhoeae

The test is looking for presence of the bacterium Neisseria gonorrhoeae, which causes the sexually transmitted disease gonorrhea. The Centers for Disease Control and Prevention (CDC) estimates that more than 700,000 people in the U.S. get new gonorrheal infections each year. While many men with gonorrhea will experience symptoms, most women do not, or will mistake gonorrhea symptoms for a bladder or other vaginal infection. For men, symptoms usually appear within 2 to 5 days of infection but can take up to 30 days. Women who experience symptoms usually do so within 10 days of infection.